Neoplasms

3,817 trials 1,526 recruiting

Filter these 3,817 trials by phase, country and sponsor.

Open in Search →

Randomised phase III trial of ADT +/- darolutamide in frail men with castration-naïve de novo metastatic prostate cancer Recruiting

2022-502425-18-00 Adenocarcinoma of the prostate 5 2022-04-19
Phase I/II trial of meclofenamate in progressive MGMT-methylated glioblastoma under temozolomide second-line therapy (MecMeth/ NOA-24) Recruiting

2024-511264-89-00 Glioblastoma 4 2022-04-11
A prospective, randomized, multicenter, comparative study of the efficacy of imatinib resumption combined with atezolizumab versus imatinib … Recruiting

2022-503068-34-00 Metastatic Gastrointestinal Stromal Tumor 4 2022-04-06
A phase I study of the mesothelin x cd47 antibody NI-1801, as single agent and in combination with anti-pd-1 antibody, or with paclitaxel al… Recruiting

2024-517752-35-00 Advanced, metastatic, or recurrent solid mesothelin-exp 1 2022-04-04
A Phase 1b Open-Label Study to Evaluate the Safety and Anti-cancer Activity of Loncastuximab Tesirine in Combination with Other Anti-cancer … Recruiting

2024-512089-32-00 Relapsed or Refractory B-cell Non-Hodgkin Lymphoma 3 2022-03-28
The efficacy of the addition of TRAstuzumab and Pertuzumab to neoadjuvant chemoradiation: a randomized multi-center study in resectable HER2… Recruiting

2024-513797-22-00 HER2 positive esophageal adenocarcinoma 5 2022-03-09
Combined Nabpaclitaxel Pressurized IntraPeritoneal Aerosol Chemotherapy with systemic Nabpaclitaxel-Gemcitabine chemotherapy for pancreatic … Recruiting

2024-518938-81-00 Pancreatic cancer with peritoneal metastases 4 2022-03-09
A Phase 1/2 Study of the Highly Selective ROS1 Inhibitor NVL-520 in Patients with Advanced NSCLC and Other Solid Tumors (ARROS-1) Recruiting

2024-511793-71-00 Advanced ROS1-positive NSCLC and other advanced ROS1-po 7 2022-02-28
EORTC 1820-CLTF: Open-Label, phase II, Multi-Center, study of Anti-CCR4 Monoclonal Antibody (mogamulizumab) Plus Total Skin Electron Beam th… Recruiting

2022-502434-10-00 Cutaneous T-cell lymphoma, a category of cancers of lym 4 2022-02-22
HERES trial: Trastuzumab and standard treatment with chemo- and immunotherapy as first line treatment for HER2 positive esophageal squamous … Recruiting

2024-516318-40-02 Esophageal Cancer 4 2022-02-21
Induction treatment of patients with head and neck squamous cell carcinoma using simultaneous chemotherapy and low-dose radiotherapy (iCHRTL… Recruiting

2024-517480-23-00 Head and neck squamous cell carcinoma 4 2022-02-17
Multicentre Phase IV clinical trial to evaluate the efficacy of hyperthermic intraoperative chemotherapy (HIPEC) with Mitomycin-C after comp… Recruiting

2024-512726-28-00 peritoneal metastases of colorectal cancer 6 2022-02-14
Study evaluating the tailored management of locally-advanced rectal carcinoma Recruiting

2024-511609-44-00 Rectum cancer 10 2022-02-03
Evaluation of an initial treatment with bevacizumab in combination with chemotherapy and then in combination with niraparib in maintenance i… Recruiting

2023-504166-37-00 Advanced ovarian, tubal or peritoneal cancer. 4 2022-02-01
A Safety Study of PF-08046040/SEA-CD70 in Patients with Myeloid Malignancies Recruiting

2023-506945-42-00 Acute myeloid leukaemia 1 2022-01-21
An Italian multicenter trial with Temozolomide taken daily at low doses continuously in patients with well differentiated neuroendocrine neo… Recruiting

2024-510898-24-00 Patients with well differentiated neuroendocrine neopla 4 2022-01-14
A Study with ABBV-CLS-484 Alone and in Combination in Subjects with Advanced Tumor Cancer Recruiting

2023-507568-38-00 Metastatic or locally advanced tumors 1 2022-01-14
Efficacy of Gembrax Followed by Folfirinox Versus Folfirinox Alone in First Metastatic Line Pancreatic Cancer Patients Recruiting

2023-508594-84-00 Metastatic pancreatic adenocarcinoma 4 2022-01-11
Treatment with venetoclax consolidated with ibrutinib and rituximab to increase the possibility of minimal residual disease in patient with … Recruiting

2024-514687-33-00 Previously Untreated Chronic Lymphophatic Leukaemia 4 2021-12-21
Study evaluating the interest of imatinib treatment maintenance or interruption after at least 10 years of treatment in patients with locall… Recruiting

2024-512631-77-00 locally advanced or metastatic Gastrointestinal Stromal 4 2021-12-20
Phase 1 Study of MK-1084 in KRAS mutant advanced solid tumors Recruiting

2022-501563-40-00 Solid tumor cancer and lung cancer 1 2021-12-16
STUDY TO ASSESS THE SCHEMAS OF RETREATMENT WITH LUTATHERA® IN PATIENTS WITH NEW PROGRESSION OF INTESTINAL WELL-DIFFERENTIATED NEUROENDOCRINE… Recruiting

2024-511001-28-00 Neuroendocrine tumor 4 2021-12-13
Randomized study to protect from radiation iatrogenic hypothyroidism patients with medulloblastoma (any stage, any biological risk) and pedi… Recruiting

2024-512642-42-00 Hodgkin and non Hodgkin lymphoma 5 2021-12-13
A study to evaluate the Safety, Pharmacokinetics, and Activity of Subcutaneous Cevostamab (BFCR4350A) in Patients with Relapsed or Refractor… Recruiting

2023-503404-89-00 Relapsed or Refractory Multiple Myeloma R/R MM 3 2021-12-08